Loading…
121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study
Saved in:
Published in: | European journal of cancer (1990) 2024-10, Vol.211, p.114644, Article 114644 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | 114644 |
container_title | European journal of cancer (1990) |
container_volume | 211 |
creator | Boni, V. Antras, J. Fuentes Garralda, E. Saavedra, O. Colombo, I. Stathis, A. Homicsko, K. Braña, I. Costanzo, S. Gruber, D. Cesano, A. Flückiger-Mangual, S. |
description | |
doi_str_mv | 10.1016/j.ejca.2024.114644 |
format | article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_ejca_2024_114644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804924013352</els_id><sourcerecordid>S0959804924013352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c964-73f67a25272b29a1021b1597619a3f5ef6b1ca27c46453168984c3f2c5c72dc53</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRbMAiVL4AVazBKlJbefpig2teFSqRBfZW47tEEdJHNluUf-DDyZVWbMaaTTnau4JggeMIoxwtmwj1QoeEUSSCOMkS5KrYIZoSsMCJfQmuHWuRQjlRYJmwQ8mGB73a4zo0wrKEpN0OiML4NDor6Y7gVOdEl4fFVTW9EaanusB9NDoSntjwdSwWe-XY4zQYlrDyL1Wg3fwrX0DXB75IJQEZzotwR96Y90K-ACHUXKvwAzgGwVjw52CLTh_kKe74LrmnVP3f3MelG-v5eYj3H2-bzcvu1DQLAnzuM5yTlKSk4pQjhHBFU5pnmHK4zpVdVZhwUkuJgVpjLOCFomIayJSkRMp0ngekEussMY5q2o2Wt1ze2IYsbNK1rKzSnZWyS4qJ-j5AqnpsaNWljkx9Z0qajt5YtLo__BfHLF7iA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study</title><source>Elsevier</source><creator>Boni, V. ; Antras, J. Fuentes ; Garralda, E. ; Saavedra, O. ; Colombo, I. ; Stathis, A. ; Homicsko, K. ; Braña, I. ; Costanzo, S. ; Gruber, D. ; Cesano, A. ; Flückiger-Mangual, S.</creator><creatorcontrib>Boni, V. ; Antras, J. Fuentes ; Garralda, E. ; Saavedra, O. ; Colombo, I. ; Stathis, A. ; Homicsko, K. ; Braña, I. ; Costanzo, S. ; Gruber, D. ; Cesano, A. ; Flückiger-Mangual, S.</creatorcontrib><identifier>ISSN: 0959-8049</identifier><identifier>DOI: 10.1016/j.ejca.2024.114644</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>European journal of cancer (1990), 2024-10, Vol.211, p.114644, Article 114644</ispartof><rights>2024 Elsevier LTD. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Boni, V.</creatorcontrib><creatorcontrib>Antras, J. Fuentes</creatorcontrib><creatorcontrib>Garralda, E.</creatorcontrib><creatorcontrib>Saavedra, O.</creatorcontrib><creatorcontrib>Colombo, I.</creatorcontrib><creatorcontrib>Stathis, A.</creatorcontrib><creatorcontrib>Homicsko, K.</creatorcontrib><creatorcontrib>Braña, I.</creatorcontrib><creatorcontrib>Costanzo, S.</creatorcontrib><creatorcontrib>Gruber, D.</creatorcontrib><creatorcontrib>Cesano, A.</creatorcontrib><creatorcontrib>Flückiger-Mangual, S.</creatorcontrib><title>121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study</title><title>European journal of cancer (1990)</title><issn>0959-8049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRbMAiVL4AVazBKlJbefpig2teFSqRBfZW47tEEdJHNluUf-DDyZVWbMaaTTnau4JggeMIoxwtmwj1QoeEUSSCOMkS5KrYIZoSsMCJfQmuHWuRQjlRYJmwQ8mGB73a4zo0wrKEpN0OiML4NDor6Y7gVOdEl4fFVTW9EaanusB9NDoSntjwdSwWe-XY4zQYlrDyL1Wg3fwrX0DXB75IJQEZzotwR96Y90K-ACHUXKvwAzgGwVjw52CLTh_kKe74LrmnVP3f3MelG-v5eYj3H2-bzcvu1DQLAnzuM5yTlKSk4pQjhHBFU5pnmHK4zpVdVZhwUkuJgVpjLOCFomIayJSkRMp0ngekEussMY5q2o2Wt1ze2IYsbNK1rKzSnZWyS4qJ-j5AqnpsaNWljkx9Z0qajt5YtLo__BfHLF7iA</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Boni, V.</creator><creator>Antras, J. Fuentes</creator><creator>Garralda, E.</creator><creator>Saavedra, O.</creator><creator>Colombo, I.</creator><creator>Stathis, A.</creator><creator>Homicsko, K.</creator><creator>Braña, I.</creator><creator>Costanzo, S.</creator><creator>Gruber, D.</creator><creator>Cesano, A.</creator><creator>Flückiger-Mangual, S.</creator><general>Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202410</creationdate><title>121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study</title><author>Boni, V. ; Antras, J. Fuentes ; Garralda, E. ; Saavedra, O. ; Colombo, I. ; Stathis, A. ; Homicsko, K. ; Braña, I. ; Costanzo, S. ; Gruber, D. ; Cesano, A. ; Flückiger-Mangual, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c964-73f67a25272b29a1021b1597619a3f5ef6b1ca27c46453168984c3f2c5c72dc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boni, V.</creatorcontrib><creatorcontrib>Antras, J. Fuentes</creatorcontrib><creatorcontrib>Garralda, E.</creatorcontrib><creatorcontrib>Saavedra, O.</creatorcontrib><creatorcontrib>Colombo, I.</creatorcontrib><creatorcontrib>Stathis, A.</creatorcontrib><creatorcontrib>Homicsko, K.</creatorcontrib><creatorcontrib>Braña, I.</creatorcontrib><creatorcontrib>Costanzo, S.</creatorcontrib><creatorcontrib>Gruber, D.</creatorcontrib><creatorcontrib>Cesano, A.</creatorcontrib><creatorcontrib>Flückiger-Mangual, S.</creatorcontrib><collection>CrossRef</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boni, V.</au><au>Antras, J. Fuentes</au><au>Garralda, E.</au><au>Saavedra, O.</au><au>Colombo, I.</au><au>Stathis, A.</au><au>Homicsko, K.</au><au>Braña, I.</au><au>Costanzo, S.</au><au>Gruber, D.</au><au>Cesano, A.</au><au>Flückiger-Mangual, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study</atitle><jtitle>European journal of cancer (1990)</jtitle><date>2024-10</date><risdate>2024</risdate><volume>211</volume><spage>114644</spage><pages>114644-</pages><artnum>114644</artnum><issn>0959-8049</issn><pub>Elsevier Ltd</pub><doi>10.1016/j.ejca.2024.114644</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8049 |
ispartof | European journal of cancer (1990), 2024-10, Vol.211, p.114644, Article 114644 |
issn | 0959-8049 |
language | eng |
recordid | cdi_crossref_primary_10_1016_j_ejca_2024_114644 |
source | Elsevier |
title | 121 (PB109): TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A42%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=121%20(PB109):%20TT125-802,%20a%20highly%20selective%20bromodomain%20inhibitor%20of%20CBP/p300,%20in%20patients%20with%20advanced%20solid%20tumors:%20an%20update%20on%20the%20phase%20I%20study&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Boni,%20V.&rft.date=2024-10&rft.volume=211&rft.spage=114644&rft.pages=114644-&rft.artnum=114644&rft.issn=0959-8049&rft_id=info:doi/10.1016/j.ejca.2024.114644&rft_dat=%3Celsevier_cross%3ES0959804924013352%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c964-73f67a25272b29a1021b1597619a3f5ef6b1ca27c46453168984c3f2c5c72dc53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |